actin a3853 Search Results


93
ProSci Incorporated anti actin a3853
Anti Actin A3853, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/actin+a3853/pmc05583178-283-64-52?v=ProSci+Incorporated
Average 93 stars, based on 1 article reviews
anti actin a3853 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

96
Biosynth Carbosynth anti actin
Anti Actin, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/actin+a3853/pm23777914-62-0-14?v=Biosynth+Carbosynth
Average 96 stars, based on 1 article reviews
anti actin - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
Merck KGaA anti -actin clone ac-40 a3853
ABCC3, CPS1, <t>and</t> <t>TRIP6</t> expression in paclitaxel-resistant NCI/ADR-RES, SKOV-3/RES, and OVCAR-3/RES. ( A ) Bar graph showing relative expression of ABCC3, CPS1 and TRIP6 genes in paclitaxel-resistant ovarian cancer cell lines (technical triplicates). ( B ) Representative immunoblots of CPS1 in paclitaxel-resistant ovarian carcinoma cell lines. CPS1 silenced SKOV-3/RES cells or non-specific siRNA transfected SKOV-3/RES cells and human liver tissue were used as controls. ( C ) Representative immunoblot of ABCC3 in paclitaxel-resistant cell lines. ABCC3 silenced MCF-7/RES breast cancer cells or non-specific siRNA transfected MCF-7/PacR breast cancer cells and human liver tissue were used as controls. ( D ) Representative immunoblot of TRIP6 in paclitaxel-resistant ovarian carcinoma cell lines. <t>β-ACTIN</t> served as a loading control. The size of TRIP6 band was confirmed previously by us .
Anti Actin Clone Ac 40 A3853, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/actin+a3853/pmc08744980-288-19-24?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
anti -actin clone ac-40 a3853 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Merck & Co β actin a3853
ABCC3, CPS1, <t>and</t> <t>TRIP6</t> expression in paclitaxel-resistant NCI/ADR-RES, SKOV-3/RES, and OVCAR-3/RES. ( A ) Bar graph showing relative expression of ABCC3, CPS1 and TRIP6 genes in paclitaxel-resistant ovarian cancer cell lines (technical triplicates). ( B ) Representative immunoblots of CPS1 in paclitaxel-resistant ovarian carcinoma cell lines. CPS1 silenced SKOV-3/RES cells or non-specific siRNA transfected SKOV-3/RES cells and human liver tissue were used as controls. ( C ) Representative immunoblot of ABCC3 in paclitaxel-resistant cell lines. ABCC3 silenced MCF-7/RES breast cancer cells or non-specific siRNA transfected MCF-7/PacR breast cancer cells and human liver tissue were used as controls. ( D ) Representative immunoblot of TRIP6 in paclitaxel-resistant ovarian carcinoma cell lines. <t>β-ACTIN</t> served as a loading control. The size of TRIP6 band was confirmed previously by us .
β Actin A3853, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/actin+a3853/pm41616836-54-4-9?v=Merck+%26+Co
Average 86 stars, based on 1 article reviews
β actin a3853 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology anti actin
ABCC3, CPS1, <t>and</t> <t>TRIP6</t> expression in paclitaxel-resistant NCI/ADR-RES, SKOV-3/RES, and OVCAR-3/RES. ( A ) Bar graph showing relative expression of ABCC3, CPS1 and TRIP6 genes in paclitaxel-resistant ovarian cancer cell lines (technical triplicates). ( B ) Representative immunoblots of CPS1 in paclitaxel-resistant ovarian carcinoma cell lines. CPS1 silenced SKOV-3/RES cells or non-specific siRNA transfected SKOV-3/RES cells and human liver tissue were used as controls. ( C ) Representative immunoblot of ABCC3 in paclitaxel-resistant cell lines. ABCC3 silenced MCF-7/RES breast cancer cells or non-specific siRNA transfected MCF-7/PacR breast cancer cells and human liver tissue were used as controls. ( D ) Representative immunoblot of TRIP6 in paclitaxel-resistant ovarian carcinoma cell lines. <t>β-ACTIN</t> served as a loading control. The size of TRIP6 band was confirmed previously by us .
Anti Actin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/actin+a3853/pmc03094068-348-12-13?v=Santa+Cruz+Biotechnology
Average 96 stars, based on 1 article reviews
anti actin - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

93
Bethyl a3853
ABCC3, CPS1, <t>and</t> <t>TRIP6</t> expression in paclitaxel-resistant NCI/ADR-RES, SKOV-3/RES, and OVCAR-3/RES. ( A ) Bar graph showing relative expression of ABCC3, CPS1 and TRIP6 genes in paclitaxel-resistant ovarian cancer cell lines (technical triplicates). ( B ) Representative immunoblots of CPS1 in paclitaxel-resistant ovarian carcinoma cell lines. CPS1 silenced SKOV-3/RES cells or non-specific siRNA transfected SKOV-3/RES cells and human liver tissue were used as controls. ( C ) Representative immunoblot of ABCC3 in paclitaxel-resistant cell lines. ABCC3 silenced MCF-7/RES breast cancer cells or non-specific siRNA transfected MCF-7/PacR breast cancer cells and human liver tissue were used as controls. ( D ) Representative immunoblot of TRIP6 in paclitaxel-resistant ovarian carcinoma cell lines. <t>β-ACTIN</t> served as a loading control. The size of TRIP6 band was confirmed previously by us .
A3853, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/actin+a3853/pm30626973-619-83-75?v=Bethyl
Average 93 stars, based on 1 article reviews
a3853 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

N/A
CRISPR/Cas9 KO Plasmids consists of Sm B/B′/N-specific 20 nt guide RNA sequences derived from the GeCKO (v2) library. For CRISPR gene knockout, gRNA sequences direct the Cas9 protein to induce a site-specific double strand break
  Buy from Supplier

N/A
Target species: human. CRISPR/Cas9 KO Plasmids consists of ZNF625-specific 20 nt guide RNA sequences derived from the GeCKO (v2) library. For CRISPR gene knockout, gRNA sequences direct the Cas9 protein to induce a site-specific double
  Buy from Supplier

Image Search Results


ABCC3, CPS1, and TRIP6 expression in paclitaxel-resistant NCI/ADR-RES, SKOV-3/RES, and OVCAR-3/RES. ( A ) Bar graph showing relative expression of ABCC3, CPS1 and TRIP6 genes in paclitaxel-resistant ovarian cancer cell lines (technical triplicates). ( B ) Representative immunoblots of CPS1 in paclitaxel-resistant ovarian carcinoma cell lines. CPS1 silenced SKOV-3/RES cells or non-specific siRNA transfected SKOV-3/RES cells and human liver tissue were used as controls. ( C ) Representative immunoblot of ABCC3 in paclitaxel-resistant cell lines. ABCC3 silenced MCF-7/RES breast cancer cells or non-specific siRNA transfected MCF-7/PacR breast cancer cells and human liver tissue were used as controls. ( D ) Representative immunoblot of TRIP6 in paclitaxel-resistant ovarian carcinoma cell lines. β-ACTIN served as a loading control. The size of TRIP6 band was confirmed previously by us .

Journal: International Journal of Molecular Sciences

Article Title: The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes

doi: 10.3390/ijms23010073

Figure Lengend Snippet: ABCC3, CPS1, and TRIP6 expression in paclitaxel-resistant NCI/ADR-RES, SKOV-3/RES, and OVCAR-3/RES. ( A ) Bar graph showing relative expression of ABCC3, CPS1 and TRIP6 genes in paclitaxel-resistant ovarian cancer cell lines (technical triplicates). ( B ) Representative immunoblots of CPS1 in paclitaxel-resistant ovarian carcinoma cell lines. CPS1 silenced SKOV-3/RES cells or non-specific siRNA transfected SKOV-3/RES cells and human liver tissue were used as controls. ( C ) Representative immunoblot of ABCC3 in paclitaxel-resistant cell lines. ABCC3 silenced MCF-7/RES breast cancer cells or non-specific siRNA transfected MCF-7/PacR breast cancer cells and human liver tissue were used as controls. ( D ) Representative immunoblot of TRIP6 in paclitaxel-resistant ovarian carcinoma cell lines. β-ACTIN served as a loading control. The size of TRIP6 band was confirmed previously by us .

Article Snippet: Following primary antibodies were applied onto the membranes and incubated overnight at 4 °C: anti -TRIP6 (HPA052813) and anti -ACTIN (clone AC-40) (A3853) from Merck (Darmstadt, Germany), anti -CPS1 [EPR7493-3] (ab129076) from Abcam (Cambridge, UK) and anti-MRP3 (PA5-23653) from ThermoFisher.

Techniques: Expressing, Western Blot, Transfection, Control

Significant differences in the mRNA levels of ( A ) CPS1 and ( B ) TRIP6 genes and ( C ) CPS1 and TRIP6 proteins in ovarian carcinoma mouse xenografts after the treatment with paclitaxel and novel SB-Ts in vivo. ( A , B ) Gene expression differences are shown as a mean of fold change (2 −∆∆CT ) ± SD, between the control group (Group I), group treated with 10 mg/kg paclitaxel (Group II), 9 mg/kg paclitaxel + 1 mg/kg SB-T-121605 (Group III), 7 mg/kg paclitaxel + 3 mg/kg SB-T-121605 (Group IV), 9 mg/kg paclitaxel + 1 mg/kg SB-T-121606 (Group V), and 7 mg/kg paclitaxel + 3 mg/kg SB-T-121606 (Group VI). Statistical analysis was performed by the two-tailed Student´s t -test * p < 0.05, ** p < 0.01, *** p < 0.001). ( C ) Representative immunoblot of CPS1, TRIP6, and β-ACTIN proteins in each group of mouse xenografts. Each group consisted of five mice.

Journal: International Journal of Molecular Sciences

Article Title: The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes

doi: 10.3390/ijms23010073

Figure Lengend Snippet: Significant differences in the mRNA levels of ( A ) CPS1 and ( B ) TRIP6 genes and ( C ) CPS1 and TRIP6 proteins in ovarian carcinoma mouse xenografts after the treatment with paclitaxel and novel SB-Ts in vivo. ( A , B ) Gene expression differences are shown as a mean of fold change (2 −∆∆CT ) ± SD, between the control group (Group I), group treated with 10 mg/kg paclitaxel (Group II), 9 mg/kg paclitaxel + 1 mg/kg SB-T-121605 (Group III), 7 mg/kg paclitaxel + 3 mg/kg SB-T-121605 (Group IV), 9 mg/kg paclitaxel + 1 mg/kg SB-T-121606 (Group V), and 7 mg/kg paclitaxel + 3 mg/kg SB-T-121606 (Group VI). Statistical analysis was performed by the two-tailed Student´s t -test * p < 0.05, ** p < 0.01, *** p < 0.001). ( C ) Representative immunoblot of CPS1, TRIP6, and β-ACTIN proteins in each group of mouse xenografts. Each group consisted of five mice.

Article Snippet: Following primary antibodies were applied onto the membranes and incubated overnight at 4 °C: anti -TRIP6 (HPA052813) and anti -ACTIN (clone AC-40) (A3853) from Merck (Darmstadt, Germany), anti -CPS1 [EPR7493-3] (ab129076) from Abcam (Cambridge, UK) and anti-MRP3 (PA5-23653) from ThermoFisher.

Techniques: In Vivo, Gene Expression, Control, Two Tailed Test, Western Blot